128 / 1631
Phase II Trial of Pembrolizumab and Radiotherapy
in Cutaneous T cell lymphoma
Chief investigator Professor Tim Illidge
Trial Sponsor:
University College London
Trial Sponsor reference:
UCL/17/0053
Trial funder(s):
Merck Sharp & Dohme Limited
Funder(s) reference:
MISP# 52167
Clinicaltrials.gov no:
NCT03385226
TBC
EUDRACT no:
2017-000433-30
CTA no:
TBC